NASDAQ:SRLS - SeraCare Life Sciences Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
SeraCare Life Sciences, Inc. (SeraCare) serves the global life sciences industry by providing products and services to facilitate the discovery, development and production of human and animal diagnostics and therapeutics. The Company's portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, bio banking and contract research services. It operates two segments: Diagnostic and Biopharmaceutical Products, and BioServices. The Diagnostic & Biopharmaceutical Products segment includes two types of products: controls and panels. The Bio Services segment includes bio banking, sample processing and testing services for research and clinical trials, and contract research services in molecular biology, virology, immunology and biochemistry.

Receive SRLS News and Ratings via Email

Sign-up to receive the latest news and ratings for SRLS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:SRLS
CUSIPN/A
Phone+1-508-2446400

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

SeraCare Life Sciences (NASDAQ:SRLS) Frequently Asked Questions

What is SeraCare Life Sciences' stock symbol?

SeraCare Life Sciences trades on the NASDAQ under the ticker symbol "SRLS."

Has SeraCare Life Sciences been receiving favorable news coverage?

Media coverage about SRLS stock has been trending positive this week, InfoTrie reports. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. SeraCare Life Sciences earned a coverage optimism score of 2.7 on InfoTrie's scale. They also gave headlines about the company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of SeraCare Life Sciences?

Shares of SRLS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is SeraCare Life Sciences' official website?

The official website for SeraCare Life Sciences is http://www.seracare.com/.

How can I contact SeraCare Life Sciences?

SeraCare Life Sciences' mailing address is 37 Birch St, MILFORD, MA 01757-5501, United States. The company can be reached via phone at +1-508-2446400.


MarketBeat Community Rating for SeraCare Life Sciences (NASDAQ SRLS)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  42 (Vote Outperform)
Underperform Votes:  49 (Vote Underperform)
Total Votes:  91
MarketBeat's community ratings are surveys of what our community members think about SeraCare Life Sciences and other stocks. Vote "Outperform" if you believe SRLS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRLS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel